Global Oral Proteins and Peptides Market Size, Share, Growth Analysis Report - Forecast 2034
Oral Proteins and Peptides Market By Drug Type (Octreotide, Insulin, Calcitonin, Plecanatide, and Linaclotide), By Application (Hormonal Disorders, Diabetes, Bone Diseases, and Gastric & Digestive Disorders), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 166 Report Code: ZMR-3360
Published Date: Apr-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 7.88 Billion | USD 44.58 Billion | 21.2% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Oral Proteins and Peptides Market, (2022 - 2028) (USD Billion)
- 2.2 Global Oral Proteins and Peptides Market : snapshot
- Chapter 3. Global Oral Proteins and Peptides Market - Industry Analysis
- 3.1 Oral Proteins and Peptides Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increase in chronic disease around the world can boost the demand for oral proteins and peptides
- 3.3 Market Restraints
- 3.3.1. High costs associated with the development and formulation of peptide therapeutics may hinder the market growth
- 3.4 Market Opportunities
- 3.4.1. Increasing research activities in oral peptide formulations may drive the market during the forecast period
- 3.5 Market Challenges
- 3.5.1. Difficulties with the metabolism and formulation of therapeutics pose a major challenge to market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Type
- 3.7.2 Market attractiveness analysis By Application
- Chapter 4. Global Oral Proteins and Peptides Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Oral Proteins and Peptides Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Oral Proteins and Peptides Market - Drug Type Analysis
- 5.1 Global Oral Proteins and Peptides Market overview: By Drug Type
- 5.1.1 Global Oral Proteins and Peptides Market share, By Drug Type, 2021 and 2028
- 5.2 Octreotide
- 5.2.1 Global Oral Proteins and Peptides Market by Octreotide, 2022 - 2028 (USD Billion)
- 5.3 Insulin
- 5.3.1 Global Oral Proteins and Peptides Market by Insulin, 2022 - 2028 (USD Billion)
- 5.4 Calcitonin
- 5.4.1 Global Oral Proteins and Peptides Market by Calcitonin, 2022 - 2028 (USD Billion)
- 5.5 Plecanatide
- 5.5.1 Global Oral Proteins and Peptides Market by Plecanatide, 2022 - 2028 (USD Billion)
- 5.6 Linaclotide
- 5.6.1 Global Oral Proteins and Peptides Market by Linaclotide, 2022 - 2028 (USD Billion)
- 5.1 Global Oral Proteins and Peptides Market overview: By Drug Type
- Chapter 6. Global Oral Proteins and Peptides Market - Application Analysis
- 6.1 Global Oral Proteins and Peptides Market overview: By Application
- 6.1.1 Global Oral Proteins and Peptides Market share, By Application, 2021 and 2028
- 6.2 Hormonal Disorders
- 6.2.1 Global Oral Proteins and Peptides Market by Hormonal Disorders, 2022 - 2028 (USD Billion)
- 6.3 Diabetes
- 6.3.1 Global Oral Proteins and Peptides Market by Diabetes, 2022 - 2028 (USD Billion)
- 6.4 Bone Diseases
- 6.4.1 Global Oral Proteins and Peptides Market by Bone Diseases, 2022 - 2028 (USD Billion)
- 6.5 Gastric & Digestive Disorders
- 6.5.1 Global Oral Proteins and Peptides Market by Gastric & Digestive Disorders, 2022 - 2028 (USD Billion)
- 6.1 Global Oral Proteins and Peptides Market overview: By Application
- Chapter 7. Oral Proteins and Peptides Market - Regional Analysis
- 7.1 Global Oral Proteins and Peptides Market Regional Overview
- 7.2 Global Oral Proteins and Peptides Market Share, by Region, 2021 & 2028 (USD Billion)
- 7.3. North America
- 7.3.1 North America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.3.1.1 North America Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.3.1 North America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.4 North America Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
- 7.4.1 North America Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 North America Oral Proteins and Peptides Market, by Application, 2022 - 2028
- 7.5.1 North America Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.4.2.1 Europe Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.4.2 Europe Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.4 Europe Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
- 7.4.1 Europe Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 Europe Oral Proteins and Peptides Market, by Application, 2022 - 2028
- 7.5.1 Europe Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.5.3.1 Asia Pacific Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.5.3 Asia Pacific Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.4 Asia Pacific Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
- 7.4.1 Asia Pacific Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 Asia Pacific Oral Proteins and Peptides Market, by Application, 2022 - 2028
- 7.5.1 Asia Pacific Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.6.4.1 Latin America Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.6.4 Latin America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.4 Latin America Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
- 7.4.1 Latin America Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 Latin America Oral Proteins and Peptides Market, by Application, 2022 - 2028
- 7.5.1 Latin America Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.7.5 The Middle-East and Africa Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 7.4 The Middle-East and Africa Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
- 7.4.1 The Middle-East and Africa Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 The Middle-East and Africa Oral Proteins and Peptides Market, by Application, 2022 - 2028
- 7.5.1 The Middle-East and Africa Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Proxima Concepts Limited (Diabetology Ltd.)
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Allergan plc
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Biocon Limited
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Chiasma Inc.
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Generex Biotechnology Corp.
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Hovione Limited
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Synergy Pharmaceuticals Inc.
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 AstraZeneca plc
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Novo Nordisk A/S
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Tarsa Therapeutics Inc.
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Sanofi S.A.
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 F. Hoffmann-La Roche AG
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Synthetic Biologics Inc.
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 Novartis International AG.
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.1 Proxima Concepts Limited (Diabetology Ltd.)
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Oral Proteins and Peptides Market attractiveness, By Drug Type
- 6. Global Oral Proteins and Peptides Market attractiveness, By Application
- 7. Global Oral Proteins and Peptides Market share by Drug Type, 2022 and 2028 (USD Billion)
- 8. Global Oral Proteins and Peptides Market by Octreotide, 2022 - 2028 (USD Billion)
- 9. Global Oral Proteins and Peptides Market by Insulin, 2022 - 2028 (USD Billion)
- 10. Global Oral Proteins and Peptides Market by Calcitonin, 2022 - 2028 (USD Billion)
- 11. Global Oral Proteins and Peptides Market by Plecanatide, 2022 - 2028 (USD Billion)
- 12. Global Oral Proteins and Peptides Market by Linaclotide, 2022 - 2028 (USD Billion)
- 13. Global Oral Proteins and Peptides Market share by Application, 2022 and 2028 (USD Billion)
- 14. Global Oral Proteins and Peptides Market by Hormonal Disorders, 2022 - 2028 (USD Billion)
- 15. Global Oral Proteins and Peptides Market by Diabetes, 2022 - 2028 (USD Billion)
- 16. Global Oral Proteins and Peptides Market by Bone Diseases, 2022 - 2028 (USD Billion)
- 17. Global Oral Proteins and Peptides Market by Gastric & Digestive Disorders, 2022 - 2028 (USD Billion)
- 18. Global Oral Proteins and Peptides Market share, by Region, 2022 and 2028
- 19. North America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 20. Europe Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 21. Asia Pacific Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 22. Latin America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
- 23. The Middle-East and Africa Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
Table Of Tables
- 1. Global Oral Proteins and Peptides Market: Snapshot
- 2. Drivers of the Oral Proteins and Peptides Market: impact analysis
- 3. North America Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 4. North America Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 5. U.S. Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 6. U.S. Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 7. Canada Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 8. Canada Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 9. Europe Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 10. Europe Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 11. Germany Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 12. Germany Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 13. France Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 14. France Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 15. U.K. Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 16. U.K. Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 17. Italy Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 18. Italy Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 19. Spain Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 20. Spain Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 21. Rest of Europe Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 22. Rest of Europe Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 23. Asia Pacific Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 24. Asia Pacific Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 25. China Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 26. China Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 27. Japan Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 28. Japan Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 29. India Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 30. India Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 31. South Korea Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 32. South Korea Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 33. South-East Asia Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 34. South-East Asia Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 35. Rest of Asia Pacific Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 36. Rest of Asia Pacific Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 37. Latin America Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 38. Latin America Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 39. Brazil Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 40. Brazil Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 41. Mexico Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 42. Mexico Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 43. Rest of Latin America Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 44. Rest of Latin America Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 45. The Middle-East and Africa Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 46. The Middle-East and Africa Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 47. GCC Countries Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 48. GCC Countries Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 49. South Africa Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 50. South Africa Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
- 51. Rest of Middle-East Africa Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
- 52. Rest of Middle-East Africa Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
Methodology
FrequentlyAsked Questions
The global oral proteins and peptides market is expected to grow due to rising awareness of health and fitness, increasing demand for protein-based supplements, advancements in drug delivery systems, and the growing use of oral peptides for therapeutic applications.
According to a study, the global oral proteins and peptides market size was worth around USD 7.88 Billion in 2024 and is expected to reach USD 44.58 Billion by 2034.
The global oral proteins and peptides market is expected to grow at a CAGR of 21.2% during the forecast period.
North America is expected to dominate the oral proteins and peptides market over the forecast period.
Leading players in the global oral proteins and peptides market include Proxima Concepts Limited (Diabetology Ltd.), Allergan plc, Biocon Limited, Chiasma Inc., Generex Biotechnology Corp., Hovione Limited, Synergy Pharmaceuticals Inc., AstraZeneca plc, Novo Nordisk A/S, Tarsa Therapeutics Inc., Sanofi S.A., F. Hoffmann-La Roche AG, Synthetic Biologics Inc., Novartis International AG, among others.
The report explores crucial aspects of the oral proteins and peptides market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed